MolMed S.p.A. announced earnings results for the six months ended June 30, 2017. For the six months, the company announced total operating revenues of EUR 9,819,000 compared to EUR 10,221,000 for the same period a year ago. Operating loss was EUR 6,501,000 compared to EUR 8,236,000 for the same period a year ago. Pre-tax loss was EUR 6,522,000 compared to EUR 8,379,000 for the same period a year ago. Loss for the period was EUR 6,522,000 compared to EUR 8,379,000 for the same period a year ago. Total cash flow absorbed by operating activities was EUR 6,912,000 compared to EUR 6,840,000 for the same period a year ago. Net investment in tangible assets was EUR 13,000 compared to EUR 73,000 for the same period a year ago. Net investment in other financial assets was EUR 5,006,000.